Assessing venous thromboembolism risk in lung cancer: a comprehensive evaluation of the khorana score, clinical characteristics, and incidence of thrombosis

IntroductionVenous thromboembolism (VTE) occurrence in patients with lung cancer is associated with significant morbidity and mortality. The Khorana Score (KRS) is a validated risk stratification tool developed to estimate risk of VTE in patients with cancer that incorporates clinical and laboratory...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Sean C. Dougherty, Rishika Singh, Caleb McKinney, Aditya Singh, Jack Masur, Alia C. Lynch, Ryan D. Gentzler, Wendy Novicoff, Nathan Roberts, Richard D. Hall
Format:	Artigo
Język:	Inglês
Wydane:	Frontiers Media S.A. 2026-01-01
Seria:	Frontiers in Oncology
Hasła przedmiotowe:	khorana risk score non-small cell lung cancer oncogenic driver mutation small cell lung cancer venous thromboembolism
Dostęp online:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1651192/full
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!